WOBURN, Mass.--Genetic MicroSystems announced it will begin operating in a new 30,000-square-foot facility here next week. The company, founded in 1997, is developing enabling products for genomics research and drug discovery based on a technology platform that includes proprietary approaches to creating arrays on solid supports, rapidly viewing wide fields with high resolution, and related software consumables. Its first product will be a high-performance, low-cost DNA-array-making instrument featuring high speed, consistent spot size, and high repeatability. The company also said it plans to leverage other aspects of its proprietary technology platform by producing WFMTM systems that can capture digital images of surfaces the size of a microscope slide, with submicron resolution, in times ranging from seconds to minutes. Such systems will drive the widespread use of biochip technology in genomics research, make possible rapid rare event detections for microbiological analyses, and facilitate the implementation of virtually real-time telepathology, the company said.
Genetic MicroSystems Will Operate from an Expanded Facility
Dec 21, 1998